# Biocon Pharma Limited – FDA Inspection, Jun 2, 2023

Source: https://www.keypedia.com/records/fda_inspections/biocon-pharma-limited/3bf28887-93d0-41f7-8975-1d4f7c569ae1
Source feed: FDA_Inspections

> FDA inspection 1209086 of Biocon Pharma Limited, June 02, 2023. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1209086
- Company Name: Biocon Pharma Limited
- Inspection Date: 2023-06-02
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1083851 - 2019-02-15
- FDA Inspection 1075123 - 2018-11-09
- FDA Inspection 1056467 - 2018-05-02

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/nicholas-l-hunt/2f10c080-c02e-4cc3-a8a0-0675b9c4cc6d)

Company: https://www.keypedia.com/companies/biocon-pharma-limited/c1481703-5b29-4a70-8e5b-ec9c2ddd3f80

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c